Introduction
b-Catenin is a multifunctional protein capable of connecting cadherins to the actin cytoskeleton via acatenin (Bullions and Levine, 1998) , and it has a critical role in the Wnt signaling pathway. In the absence of Wnt signaling, b-catenin is bound by the adenomatous polyposis coli (APC) tumor suppressor and either AXIN1 or AXIN2 together with glycogen synthase kinase 3b (GSK3b), which phosphorylates specific serine and threonine residues in the N-terminal domain. Phosphorylated b-catenin is destined for proteasomemediated degradation. Following association of extracellular Wnt with its transmembrane receptor Frizzled and coreceptor LRP, GSK3b is inactivated, which leads to the accumulation of b-catenin and its translocation to the nucleus (Polakis, 2000) . There b-catenin associates with transcription factors of the TCF family (Brantjes et al., 2002) and activates target genes involved in transcription, cell cycle regulation, apoptosis and matrix remodeling. Mutations and deletions of phosphorylation sites in the amino terminus result in the stabilization of b-catenin and have been identified in human tumors and cell lines (Polakis, 2000) . Elevated levels of b-catenin have been associated with poor prognosis in human adenocarcinomas of the breast (Lin et al., 2000) . Expression of an N-terminally truncated b-catenin under the control of mouse mammary tumor virus-long terminal repeat (MMTV-LTR) sequences resulted in aberrant alveolar budding, precocious alveolar development and in the formation of mammary adenocarcinomas (Imbert et al., 2001; Michaelson and Leder, 2001) .
Recently, the stabilization of b-catenin through Cremediated deletion of exon 3 (amino acids 5-80) in differentiating mammary alveolar epithelium has been demonstrated to induce transdifferentiation into epidermal-like structures, squamous metaplasias and pillar structures (Miyoshi et al., 2002) . Loss of exon 3 of the bcatenin gene in differentiating mammary epithelium was achieved with a Cre transgene under control of the WAP gene promoter. Accumulation of b-catenin led to a loss of epithelial differentiation followed by a prominent transdifferentiation into squamous metaplasias. On a histological level, the accumulation of b-catenin led to the loss of Stat5a, NKCC1 and Npt2b, with increased levels of cytokeratins K1 and K6 heralding the squamous transdifferentiation.
There is a paucity of molecular insight into the process of transdifferentiation, and this study focused on the elucidation of its molecular consequences. Towards this end, gene expression profiles for normal mammary epithelium and b-catenin-induced squamous metaplasias were established. To accomplish this goal cDNA microarrays, including one specifically designed for mammary tissue (Mammochip), were generated. The gene expression profiles were investigated in samples displaying different stages of metaplastic progression versus normal mammary tissues. New and known genes showing differential expression patterns between normal mammary tissue, squamous metaplasia and skin have been identified.
Results

Stabilized b-catenin induces transdifferentiation of mammary epithelium
Previously, our lab reported that the stabilization of endogenous b-catenin in differentiating mouse mammary epithelium leads to its transdifferentiation into epidermallike structures (Miyoshi et al., 2002) . In order to better understand the genetic steps that lead to the loss of mammary epithelial differentiation, the acquisition of epidermal features and the transdifferentiation into squamous metaplasias, we attempted to identify those genes that were repressed or activated upon the stabilization of b-catenin. For this purpose, Catnb þ /Dex3 : WAP-Cre mice were bred and two stages of transdifferentiation were chosen (Figure 1 ). The first sample (TD1) was harvested after the first pregnancy at 10 weeks of involution. It featured keratinized squamous metaplasias as well as structures resembling condensed alveoli and stromal components. At a more advanced stage (TD2) from a different animal at the same time point, very few alveolar structures had remained and the majority of the epithelium had undergone squamous transdifferentiation. The histology from each tissue was used to assign the relative stage of transdifferentiation (TD1 had less transdifferentiation than TD2). In contrast, wild-type mammary tissue from mature virgins and during involution exhibited a normal ductal structure embedded in the stroma.
Gene expression in mammary tissue from wild-type virgin, lactating and involuted mice
The mouse Mammochip was used to examine the profile of mRNA expression in virgin, lactating and involuted tissues. This chip was developed by our laboratory and contains approximately 6000 cDNA sequences isolated from different mammary-specific libraries (see Materials and methods). To validate the Mammochip, gene expression profiles from virgin, lactating and involuted mammary tissue were compared. Complementary DNA prepared from age-matched wild-type virgin mammary tissue (wtV) was used as a common partner and hybridized with cDNA prepared using mammary tissue from wild-type lactating (wtL) and involuted (wtI) mice. Out of more than 6000 cDNAs, 315 (78 known genes) were differentially expressed over threefold between the virgin and lactating states ( Table 1) :1248105, 1195450, 1067531, 820233, 963535, 1494796, 1246128, 949592, 1400033, 1396558, 1477353, 1247529, 1396449, 1248163, 1430633, 949701, 832131, 875024, 948442, 890568, 935531, 1314940, 1494848, 1068124, 891453, 1349720, 1067780, 1477336, 1066855, 850967, 1244561, 947715, 1314650, 1365243, 876530, 1314067, 863024, 820139, 876902, 875125, 1244964, 1349255, 1178983, 1066847, 876220, 1195620, 1449092, 949593, 1349472, 876625, 948774, 832048, 1244869, 876479, 1495141, 1067317, 863633, 1495233, 1068653, 1495123, 1245495, 820226, 873874, 1195532, 820307, 1195467, 1348287, 863853, 863377, 876068, 1314494, 1494744, 876329, 1245619, 1314677, 891226, 891386, 863308, 853253, 1245272, 850556, 1314249, 1347541, 1400024, 1348682, 875993, 948600, 850165, 1245974, 876374, 948585, 891400, 863283, 874657, 1398261, 1245109, 832458, 1313987, 1068850, 1178993, 890825, 1244922, 863670, 1314112, 1245164, 832481, 1313992, 1314087, 1066706, 850550, 1314031, 1399222 IMAGE:862807, 863604, 1383598, 851715, 1447704, 851739, 1195555, 1496185, 862999, 1477290, 1068765, 1247486, 890550, 1383148, 1244284, 874999, 1398969, 863781, 1177933, 1247911, 851492, 874045, 1247919, 948437, 963845, 831969, 948556, 1247669, 947677, 1366757, 1067531, 1383163, 1383141, 1496210, 1477325, 1067414, 832237, 948415, 1054191, 1494739, 963432, 1477379, 864839, 876369, 963664, 1248141, 1244320, 1066914, 948547, 1245754, 1066860, 1245777, 863361, 820209, 1396418 :1430589, 851337, 1247661, 820682, 1494877, 1511559, 832278, 1245686, 1346211, 1054643, 1448138, 1247736, 1397838, 1246820, 1448074, 874482, 1248573, 1314860, 891214, 1067847, 1054324, 1430609, 1381948, 949540, 1448100, 1054043, 1494871, 1511173, 1395749, 1510610, 1510950, 1511503, 1495042, 1245832, 1067103, 851209, 1384186, 1245672, 963526, 1348833, 1245783, 1382204 IMAGE:949074, 1510672, 1384121, 1448316, 949854, 873929, 864395, 1248009, 1448943, 1384047, 1477122, 1476966, 891107, 863639, 1247699, 1398298, 1195127, 1495974 Expression of genes associated with fat metabolism was higher in mammary tissue from virgin mice ( Table 1 ). The levels of RNA encoding a diverse set of proteins, including adipocyte complement related protein of 30 kDa (Acrp30) (Scherer et al., 1995) , resistin (McTernan et al., 2002) , fatty acid binding protein 4 (FABP4) (Yang et al., 1994) , fat-specific gene 27 (Danesch et al., 1992) , stearoyl-coenzyme A desaturase-1 (STE) (Calabro et al., 1982) , caveolin (Park et al., 2001) and carbonic anhydrase III (CA III) (Lynch et al., 1993) were 4-10-fold higher in the virgin. This expression pattern reflects to a large extent the relative distribution of various cell types at different stages of development. While virgin mammary tissue consists predominantly of stromal cells and adipocytes, tissue from lactating mice contains mainly epithelium. Approximately 30 ESTs exhibited a highly elevated level of expression in virgin tissue and some of them possibly encode novel fat-related genes.
To validate the microarray data and identify the nature of the unknown genes, the original IMAGE clones, which had been printed on the slides, were amplified and sequenced. Northern blot analyses were performed with probes for a-casein, CAIII, FABP 4 and STE (Figure 2 ) and the results obtained agreed with the microarray data and further validated the gene profiling approach.
Since the transdifferentiated tissues were obtained from mice that had gone through pregnancy, lactation and involution, control tissue from the same stage was analysed. A comparison between mammary tissue from mature virgin mice and after 10 weeks of involution displayed 52 differentially expressed genes (Table 2) . No significant expression of milk protein genes, with the exception of k-casein, was observed after complete involution and the profiles of known fat markers were identical to that seen in virgin tissue. However, the expression of several genes associated with lactation was observed after 10 weeks of involution. These include ars2 and 10 ESTs, whose corresponding genes are unknown. Equally interesting, the expression of 37 mostly unknown genes did not reach the level observed before pregnancy. Lastly, the expression levels of two unknown genes (IMAGE clones 864796 and 1396803) were higher in the involuted mammary tissue than either virgin or lactating tissue (Table 2, ratios in white). These data strongly suggest that the state of complete involution is distinct from that of a mature virgin, and that the expressed genes reflect the maintenance of remodeled tissue.
Stabilization of b-catenin in mammary epithelium results in the maintenance of expression of lactation-related and the activation of epidermal-specific genes
The gene expression profiles of two distinct stages of mammary tissue that had undergone squamous transdifferentiation were analysed using the NCI Oncochip and the Mammochip. Out of more than 9000 cDNAs, a total of 230 were differentially expressed between wild-
Northern blot analysis with genes whose expression was induced or suppressed in tissue from lactating mice based on microarray assays. Expression of a-casein was detected during lactation and to some extent in tissue sample TD1. Expression of stearoyl coenzyme A desaturase 1 (STE) was lost in the highly transdifferentiated sample TD2. Fatty-acid binding protein 4 (FABP4) and carbonic anhydrase III (CA III) have similar expression patterns as STE. The loss of lipid biosynthesis in the highly transdifferentiated sampe TD2 can be expected because of the replacement of a stroma cell population and apparent decrease in lactation-related milk products. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. V, virgin mammary tissue; L, lactation day 1 mammary tissue; I, day 10 of involution mammary tissue; S, skin; TD1, 'mammary' tissue from Catnb
:WAP-Cre mice that had gone through one pregnancy and exhibited limited transdifferentiation and remaining epithelial structures; TD2, 'mammary' tissue from Catnb
:WAP-Cre mice that had gone through one pregnancy and 10 weeks of involution. The TD2 tissue had undergone almost complete squamous transdifferentiation Identification of genes differentially expressed in mouse mammary epithelium (Tables 3 and 4) , 56 (51 known genes) were identified on the NCI Oncochip (Table 5) . The differentially expressed genes were classified in four groups. Group 1 contains genes with an elevated level of expression in both transgenic samples; group 2 contains genes that were activated only in sample TD2; group 3 encompasses genes that were preferentially active in sample TD1; and group 4 contains genes whose expression was reduced in the TD1 and TD2. Group 1 contained transcripts that were elevated in TD1 and TD2, and it included genes whose expression can be linked to epidermal differentiation and function. Transcripts for keratin 5 and a gene similar to glycolipid transfer protein (GLTP) transcripts were elevated in TD1 and TD2 (Table 3) , and also highly expressed in the skin of wild-type mice ( Figure 3 ). Elevated expression of the macrophage expressed gene 1 could be indicative of continued remodeling. Group 3 encompassed genes whose expression was elevated in TD1. These genes include those encoding the milk proteins a, b, and g-casein (Table 3 , group 3). This suggests that the activation of Wnt/bcatenin signaling results in the retention of limited epithelial differentiation even after 10 weeks of involution, a time when normally no significant expression of milk protein genes is observed ( Table 2) . As expected, expression of these genes was not elevated in sample TD2 as there was no apparent secretory epithelium at this stage ( Figure 1 ).
The expression of milk protein genes would suggest that the Stat5 signaling pathway was still active in the involuted mammary epithelium carrying an activated b-catenin gene. Since both Stat5 (Liu et al., 1997; Miyoshi et al., 2001) and Stat3 (Chapman et al., 1999; Humphreys et al., 2002) have defined roles in mammary development, we investigated their expression pattern in both the samples. Stabilization of b-catenin led to the loss of Stat5a in the transdifferentiated sample TD2, while it was retained in the less transdifferentiated sample TD1 (Figure 4 ). Stat3 levels appeared unaltered in TD1 and TD2 compared to mammary tissue and skin ( Figure 4 ). The maintenance of limited Stat5a levels in TD1 suggested the presence of functional alveoli, and the results agree with the expression of milk genes in the less differentiated tissue TD1 and the loss of expression in the highly transdifferentiated tissue TD2. The localization and activity of Stat5a was confirmed by immunohistochemistry ( Figure 4 ). While no nuclear Stat5a was observed in areas of transdifferentiation, nuclear and cytoplasmic staining was observed in the persisting alveolar structures. The presence of nuclear Stat5a may be a consequence of an impaired involution or conversely may be an event subsequent to the activation of b-catenin signaling. The expression of genes indicative of the stromal compartment (fat markers) in virgin and involuted wild-type mammary tissue was lower in both mutant samples (Table 3 , group 4), suggesting the decline of a stromal content in the transdifferentiation process.
The gene expression profile of samples TD1 and TD2 was also determined using the NCI Oncochip (Table 5) , which contains mostly known genes. Among the activated genes in both transgenic specimen were some encoding proteins involved in tissue remodeling, including prosaposin and cathepsin Z. Northern blot analyses confirmed increased levels of prosaposin and cathepsin Z mRNA in TD1 and TD2 (Figure 3) , and zymogram analysis established high levels of cathepsin Z activity in sample TD1 (Figure 6 ).
Identification of two new genes expressed upon b-catenin activation
The design of the Mammochip included a large number of ESTs without known function, thus favoring the discovery of yet unknown genes. The initial screen included analyses of candidate clones on commercial RNA blots (data not shown) and on RNAs obtained from transdifferentiated tissues ( Figure 5 ). This broad sweep identified two RNA species with interesting expression patterns. IMAGE clone 947797 did not correspond to any known gene, but matched five EST clones from retina, heart and mammary tissue. The size of the RNA transcript was approximately 1.8 kbp and it was detected in lactating mammary tissue and in sample TD1 ( Figure 5 ). Expression was also detected by Northern blot in heart, brain, spleen, liver and kidney (data not shown). IMAGE clone 1348833 had a similar expression pattern to that of caseins, but it did not correspond to any known or predicted gene. It matched to a single genomic locus on mouse chromosome 2 and lined up as four distinct exons. The two unknown genes, although similar in expression to casein genes, are located on separate chromosomes and therefore should not be a secondary effect of activating the casein locus.
There was no open reading frame that would produce a protein larger than 39 and 56 amino acids for the IMAGE clones 947797 and 1348833, respectively. These genes may produce large open reading frames after the full-length sequences are determined experimentally, but our results based on a bioinformatic approach did not prompt further analysis for our current study. There is no direct evidence that these expressed RNA sequences display a role in the transdifferentiation process, but they are clearly induced upon the activation of b-catenin.
Identification of a gene encoding a novel 20 kDa protein conserved between species
The expression levels of many unknown genes induced in the transdifferentiated tissues (Table 4) were too low to be detected in the initial screen by Northern blot. However, since some of these proteins may be causally related to the transdifferentiation process, their characterization was pursued. A bioinformatic screen was applied to define a set of genes for further analysis (Table 6 , A-C). Each unknown gene from the upregulated list in Table 4 was evaluated for its exon content, open reading frame size and predicted protein Identification of genes differentially expressed in mouse mammary epithelium
homology. Genes were identified that contained transcripts encoded by several exons, large open reading frames and no homology of the encoded protein to known proteins. Based on the criteria met in Table 6 (A-C) and the conservation between Homo sapiens, Mus musculus and Rattus norvegicus (Table 6D) , IMAGE clone 1178579 appeared to be a good candidate for an experimental characterization of the predicted open reading (Figure 6 , a-c). For this purpose, a cDNA fragment containing 41-690 bp (GenBank AY243536 and AY243537) from the corresponding RIKEN sequence (clone 2610019I03; GenBank AK011464) was generated and the open reading frame was inserted into a mammalian expression vector. To be able to identify the protein, a C-terminal myc-his tag was inserted. The expression constructs and control vectors were transiently transfected into HeLa cells and incubated for 48 h, followed by protein and RNA analyses and immunofluorescence. Western blot analysis revealed the presence of a protein with an apparent molecular weight of 23 kDa (Figure 6a ), which is in agreement with the predicted size of the myc-his fusion protein and the predicted size of approximately 20 kDa for the endogenous protein product. To further verify that the protein expression shown by Western blot was a result of the transfected expression vector, RNA was analysed from native and transfected HeLa cells with a genespecific probe (Figure 6b ). The subcelluar localization of the novel protein was determined by immunohistochemistry using the myc tag for detection (Figure 6c ). The protein was located within the nucleus when cultures were not confluent (Figure 6c , a 0 and a 00 ), but was excluded from the nucleus upon confluency (Figure 6c , b 0 and b 00 ) and in dividing cells (Figure 6c , c 0 and c 00 ). The nuclear localization has been confirmed by confocal microscopy (data not shown). There was a predominant exclusion of this protein from the nucleolus when accumulation was detected within the nucleus. There were no known regions of homology with previously described nuclear localization signal peptides as determined using several bioinformatic tools, and at this time no clear transport mechanism may be inferred. Owing to the nuclear localization properties in the subconfluent cultures and the UNIGENE Hs.208912 cluster distribution, we have named this protein PANE1 (proliferationassociated nuclear element). Based on this initial characterization, it is now possible to begin to identify a role for this primary or secondary downstream bcatenin target. The analysis of each new gene expressed in response to the initiation or maintenance of a transdifferentiation process may continue to elucidate signaling events and altered structural components that Identification of genes differentially expressed in mouse mammary epithelium J-P Renou et al 
Protease expression in b-catenin induced transdifferentiated mammary epithelium
The microarray analyses revealed the induction of genes related to the establishment and maintenance of the extracellular matrix and tissue remodeling (Table 1) . During lactation, the production of procollagen type IV a-6 was reduced (Table 1) . Collagen is a common substrate for several proteinases, and the maintenance of the basement membrane in the presence of reduced type IV collagen production indicates a lower level of net protease activity. In transdifferentiated tissues, the level of procollagen type I a-1 mRNA was about threefold higher than in virgin tissue (Table 5 ). The signals obtained for MT2-MMP and a serine/cysteine proteinase inhibitor were also reduced in the same comparison between transdifferentiated and wild-type virgin samples.
To understand the overall patterns of protease activity, the levels of gelatin and casein zymogen activity were established in transdifferentiated and wild-type tissues using gelatin and casein-embedded Tris-Glycine SDS gels. Increased zymogen activity was observed in transdifferentiated tissue (Figure 7a, b) . The sizes of the digested bands on the gelatin zyogram indicated that the majority of the signal was due to an increase in MMP2 and MMP9 net activity. On the casein gel, the size of the band suggested a possible upregulation of cathepsin activity. The arrays also identified an increased level of Cathepsin Z mRNA expression in transdifferentiated tissue. Cathepsin Z shares close homology to Cathepsin D and L (Sol-Church et al., 2000; Turk et al., 2000 Turk et al., , 2001 , which are both able to degrade casein (Dufour and Ribadeau-Dumas, 1988; Larsen et al., 1996) . Cathepsins Z, D and L are all very close to the size observed in the degradation of the casein substrate, and Northern blot analysis confirmed an increase of Cathepsin Z mRNA in transdifferentiated tissue (Figure 3) . Although the Northern blot indicated an upregulation of Cathepsin Z, it was possible that the zymogen activity observed on the casein gel may be due to the presence of Cathepsin D or L. The arrays were able to identifiy Prosaposin as upregulated in the transdifferentiated tissue (Table 5) , and this protein has been implicated in sharing a similar expression pattern with Cathepsin D (Campana et al., 1999) . Northern blot analyses revealed a similar expression pattern for Prosaposin and Cathepsin Z, suggesting that the casein degradation may be due to the expression of more than one enzyme of similar size in this region (Figure 7b) .
The zymogram assays using whole tissues indicated that a program had been initiated that leads to an increase in MMP activity. We hypothesize that this MMP activity might have been due to a transient population of cell types involved with the inflammatory response as an effect of b-catenin accumulation. We have not done any RNA localization in situ to determine the specific cell type responsible for the observed MMP activation, and this remains a subject for further study. Discussion b-Catenin is an integral component of the Wnt signaling cascade and its stabilization specifically in mammary epithelium leads to a loss of differentiation followed by transdifferentiation and the establishment of squamous metaplasias. The molecular state of transdifferentiated tissue at distinct stages of progression was assessed with cDNA microarrays. The use of the Mammochip, which contains mainly unknown genes, facilitated the identification of new genes that are activated during the b-catenin-induced transdifferentiation process. This approach also demonstrated that the activation of b-catenin signaling results in the temporal maintenance of differentiated mammary epithelium after the onset of involution and is accompanied by the maintenance of Stat5a activation as gauged by its nuclear localization. In contrast, no nuclear Stat5a was observed in the tissue that had undergone complete transdifferentiation.
The Mammochip was developed as a tool to discover new genes that are expressed in normal mouse mam- Figure 3 Northern blot analysis of known genes whose expression was altered upon the stabilization of b-catenin based on microarray assays. Keratin 5 expression was higher in sample TD2 than in any stage of mammary development. As expected, its expression was high in skin. Expression of the glycolipid transfer protein (GLTP) was limited to skin and samples TD1 and TD2. Cathepsin Z expression was dramatically increased in the sample TD1 as compared to all of the other tissues analysed, indicating that protease expression may be important during the transdifferentiation process. The pattern of prosaposin expression is similar to that of Cathepsin Z. GAPDH expression was used as a loading control. The tissue samples used were the same as in Figure 2 mary tissue and possibly control its development and physiology. The use of this chip not only verified the expression of known milk protein genes in lactating tissue, but also led to the identification of new genes highly expressed during functional differentiation. Importantly, these experiments also revealed that the gene expression profile of involuted tissue does not mimic that observed in mature virgins, and that new genes are activated specifically during the process of involution. This observation confirms on a molecular level that mammary tissue, which has completed one round of functional differentiation followed by complete involution, does not return to its original state. Based on these results we hypothesize that the expression or repression of specific genes may be necessary for the maintenance of involuted epithelium. Alternatively, a change in the cell population, such as a shift in the number of alveolar stem cells, may account for the differences. The identification of genes that distinguish the virgin from the remodeled state provides the basis to further understand these differences and the physiological consequences.
Several important lessons emerged from this study. The analysis of transdifferentiated tissue at different stages of progression led to the establishment of four groups of genes that may indicate common regulatory motifs or similar mechanisms for the relative pathway activation. Notably, on a molecular level, the transdifferentiation process resulted in the activation of epidermal-specific genes. In addition to known genes, many new genes were activated in transdifferentiated tissues. One encodes a 1.8 kbp RNA product that was detected in a restricted set of tissues, including mammary epithelium. The second gene encodes a 1.5 kbp mRNA whose expression was detected in lactating mammary tissue and in transdifferentiated tissue that still contained some epithelium. The only corresponding EST in GenBank is from a mammary library, suggesting an expression limited to mammary tissue. However, increased expression was also detected in prostate tissue that had undergone b-catenin-induced hyperproliferation and transdifferentiation (our results unpublished), suggesting a role in epithelial cell pro- liferation or expression by the infiltrating inflammatory cell types. A new gene was identified that encodes a 20 kDa protein product with a distinct subcellular distribution. Based on the nuclear localization of this protein during uninhibited growth in culture, and the preferential expression in highly proliferative tissues as determined by the UNIGENE cluster Hs.208912 distribution, the protein was named PANE1. At this point the functional role of the 20 kDa protein is not known. Although it is conserved between species, no known protein motifs were apparent.
The particular approach used in this study pointed to new genes that may contribute to, or are expressed as a result of b-catenin accumulation. This study also demonstrated an altered expression of basement membrane proteins, or those mediating its maintenance, in transdifferentiated tissue. Specifically, the increase in protease activity may reflect the remodeling process that parallels the transdifferentiation process, and possibly preceding stages of hyperproliferation. A smaller increase of cathepsins has been observed during normal involution using Affimetrix arrays (Chaudhry et al., 2002; Master et al., 2002) . The expression of the extracellular matrix modifiers may be linked to the inflammatory response rather than the direct intracellular signaling because of b-catenin accumulation. Regardless, the tissue compartment as a whole shows increased MMP activity.
Finally, profiling gene expression in normal mammary tissue and upon b-catenin-induced transdifferentiation has emerged as a viable tool to further characterize the state of transdifferentiation. The characterization of newly identified genes and an understanding of their function may continue to shed light on the molecular processes underlying the establishment or maintenance of cell specification and identity in response to the activation of b-catenin.
Material and methods
Mammary tissues
Transgenic mice harboring a stabilized endogenous bcatenin have been described (Miyoshi et al., 2002) . Briefly, exon 3 of the endogenous b-catenin gene (encoding amino acids 5-80) was flanked by loxP sites, and the deletion in differentiating mammary epithelium was accomplished with a Cre transgene under control of the WAP gene promoter. Mammary tissues from wildtype mature virgin mice, at day 1 of lactation, and 10 weeks of involution were compared with tissues from transgenic mice at 10 weeks of involution, which exhibited different degrees of metaplasias. The two mutant samples were obtained from transgenic mice that had gone through one pregnancy followed by 10 weeks of involution. We have not observed any adverse effects suggesting toxicity related to Cre expression (Loonstra et al., 2001; Pfeifer et al., 2001; Silver and Livingston, 2001 ).
Microarray analysis
The microarray analysis has been performed with both a 2.6 k NCI Oncochip mainly comprised of known genes (Mm OC 6-3; Advanced Technology Center, NCI, NIH), and a mammary-specific chip (Mammochip) comprised of mostly unknown genes. Approximately 6000 unigenes were selected as highly enriched in mammary tissue from two libraries containing a total of 52 000 sequences: Soares NbMMG GenBank ID: 403 9 (virgin) and Soares NMLMG GenBank ID: 636 (lactating). Each sequence was spotted at least twice thus generating a 12.9 k cDNA array: Mm-M-v1p1 (Advanced Technology Center, NCI, NIH), which includes about 18% known genes and 82% unknown genes. The lists are accessible at http:// nciarray.nci.nih.gov/gal_files/. RNA was prepared from mammary tissue of control mice virgin, lactation day 1, and 10-week involuted mice. RNA was prepared from bcatenin-stabilized mammary tissues that had undergone 10 weeks of involution and demonstrated differing degrees of transdifferentiation. All RNA was prepared using TRIzol extraction (Life Technologies, Rockville, MD, USA) followed by two ethanol precipitations. For fluorescence labeling, 20 mg of total RNA was reverse transcribed in the presence of 300 U SuperScript II (Life Technologies, Rockville, MD, USA), then labeled with cy3-dUTP and cy5-dUTP (NEN, Boston, MA, USA). Samples were combined, purified and concentrated with YM30 Microcon columns (Millipore, Bedford, MA, USA). Slides were prehybridized for 1 h and hybridized overnight at 421C, in 25% formamide. Slides were washed in 2 Â SSC þ 0.1% SDS 4 0 , 1 Â SSC 4 0 , 0.2 Â SSC 4 0 , 0.05 Â SSC 1 0 , and dried by centrifugation. The arrays were scanned on a GenePix 4000A scanner (Axon Instruments, Foster City, CA, USA). The images were analysed by GenePix Pro 3.0 (Axon Instruments, Foster City, CA, USA). Each experiment was repeated with switched labeling. The data were deposited in the NCI-CIT microarray database and normalized data were Figure 2 . High expression of IMAGE clone 947797 was observed in lactating mammary tissue. Expression in sample TD1 was higher than in the involuted control tissue. The expression pattern of IMAGE clone 1348833 was similar to that of clone 947797. GAPDH expression was used as a loading control analysed with mAdb tools (NCI-CIT) using the following parameters: differentially expressed genes were selected with a signal intensity of fivefold higher than the average slide background in at least one channel, and an expression ratio of at least 3 for upregulated genes or 0.3 and lower for downregulated genes. These criteria had to be met in the label and reverse-label experiments for a gene to be included in consideration for analysis of altered expression.
Northern-blot analysis
Total RNA was prepared from fresh whole tissue using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) essentially as described by the supplier's protocol. Total RNA (10 mg) was loaded in each well and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. Hybrisol 1 solution containing 50% formamide, 10% dextran sulfate, 1% SDS and blocking reagent (Intergen, Purchase, NY, USA) was used for hybridization. Prehyridization was performed at 451C for 3 h with the Hybrisol 1 solution. Sequences used to amplify the probes were: (IMAGE: 947797)
0 -R; (IMAGE:1348833, Keratin 5, a-casein, GLTP, and CA III were amplified from image clones using the common T3 and T7 primers) 5
0 -R. The probe used for the transfection studies was the Not1 and Xba1 digested fragment from the unligated sequence verified PCR product from the open reading frame of the gene represented by IMAGE clone 1178579. The radio-labeled probes were hybridized at 1.5 Â 10 6 c.p.m./ml for 18 h at 421C. After hybridization, the blots were washed two times with 2 Â SSC þ 0.1%SDS, and twice with 0.1 Â SSC þ 0.1%SDS at 421C. The blots were exposed at À801C for 3, 6, 9, 12, 15, and 24 h depending on the gene.
Western blot analysis
Protein extracts for analysis by Western blot were obtained from b-catenin conditionally stabilized females, and lysate was prepared from fresh and frozen . It is worth noting that the protein was excluded from the nucleolus when localized within the nucleus (visible in a'). DAPI is blue and the myc antibody is visible in green (Alexa Fluor 488 conjugated secondary antibody) tissues. Tissue was homogenized protein lysis buffer containing the proteinase inhibitors aprotinin, leupeptin and PMSF at 50 mg/ml. The activated phosphotyrosyl proteinase inhibitor sodium orthovanadate was prepared, and added to a final concentration of 4 mm. Total protein (40 mg) in 1 Â Tris-glycine SDS loading buffer (Invitrogen, Carlsbad, CA, USA) with BME was loaded on 8% Tris-glycine SDS gels (Invitrogen, Carlsbad, CA, USA) according to the protocol provided by the manufacturer. After the gel electrophoresis, proteins were transferred to PVDF membranes. Antibodies were diluted in 2.5% BSA blocking buffer at 1 : 500 for b-catenin (C-19220; Transduction Laboratories, San Diego, CA, USA) and a-actin (05-384; Upstate Biotechnology, Lake Placid, NY, USA); 1 : 1000 for Stat3 (SC-482; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 1 : 5000 for Stat5a (Liu et al., 1996) . The primary antibodies were allowed to incubate at room temperature for 1 h, then the membranes were washed for 5 min 3 Â using 1 Â TBST. Secondary antibody was diluted at 1 : 5000 and incubated for 45 min, and after incubation the membranes were washed for 10 min 5 Â using 1 Â TBST. HRP was detected using the Super Signal Western Detection Kit (Pierce Chemical, Rockford, IL, USA) as described by the manufacturer's protocol. In addition to a-actin as a control, loading was determined by Coomassie staining (Pierce Chemical, Rockford, IL, USA) of parallel gels.
Immunostaining
Tissues were fixed in 10% NBF at 41C overnight. After fixing, the tissues were transferred to 70% alcohol and sectioned to a depth of 5 m. After deparaffinization and rehydration, the endogenous peroxidase activity was blocked using 10% methanol þ 0.3%H 2 O 2 for 20 min followed by two washes in 1 Â PBS. Antigen unmasking solution (Vector Laboratories Incorporated, Burlingame, CA, USA) was used for antigen retrieval. The unmasking solution was diluted 1 : 100 in distilled water and the sections were microwaved in 600 ml of this solution for 20 min. The sections were blocked in 1 Â PBS þ 3% normal goat serum for 30 min at room temperature. The Stat5a antibody that has been previously described (Liu et al., 1996) and a Stat3 (SC-482; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibody were diluted in blocking solution at 1 : 600 and 1 : 400 respectively then allowed to incubate at 41C overnight. The slides were washed twice in 1 Â PBS, and the secondary antibody (Vector Laboratories Incorporated, Burlingame, CA, USA) was applied to the sections for 1 h at room temperature. After incubation with the secondary antibody, ABC reagent was added for 30 minutes at room temperature. (ABC kit; Vector Laboratories Incorporated, Burlingame, CA, USA). To detect staining, DAB peroxidase substrate (Vector Laboratories Incorporated, Burlingame, CA, USA) solution was added as described in the manufacturer's protocol (excluding addition of the nickel solution). The sections were allowed to incubate until staining was observed under the microscope. The sections were counterstained with hematoxylin using a standard protocol.
Cloning and transient transfections
IMAGE clone 1178579 was localized to a genomic region that corresponded to the RIKEN cDNA 2610019I03 clone (GenBank AK011464). All of the PCR reactions were performed using High Fidelity Taq (Invitrogen, Carlsbad, CA, USA). The primers used to amplify 41-690 bp (GenBank AY243536, AY243537) The upregulation of MMP9 is demonstrated at 92 k in both the transdifferentiated tissues. MMP2 activity observed at 72 and 62 k for the pro and active form, respectively, is higher in the TD2 sample than any of the other tissues analysed. (b) Casein embedded SDS-PAGE demonstrating degradation of the casein substrate at 30 kDa, suggesting an increase in protease activity that may include several of the Cathepsin family members. In contrast to the gelatin degrading proteases that are able to degrade type IV collagen as found in the basement membrane of wild-type mammary epithelium, the observed 30 kDa proteinase activity is expressed at a much higher level in the less transdifferentiated tissue TD1. Activity of the 30 k casein degrading protease was also observed in the skin from the RIKEN sequence were: 5 0 CTGGAGC-CGAGTGGCGCTGC-F and 5 0 CCTGTCAGGC-CCTGACTGGTC-R. The PCR product was amplified with a 551C annealing temperature for 35 cycles using lactating mammary gland and TD1 RT reaction templates. The lactating mammary gland template was used to ensure that this gene could be amplified using a common tissue source (rather than only the TD1 sample). The 5 0 Not1 and 3 0 Xba1 overhangs were produced using a nested PCR from the sequence verified product in the previous reaction. The primers used for the sticky overhangs of the open reading frame were: 5 0 ATAAGAAGGCGGCCGCATGTCGGTGCTGA-GTGCTGAGGTCGATGG-F and 5 0 CTAGTCTAG-ACAGCTCCTTGGATGGGGGGTTC-R. The PCR products were cut with Not1 and Xba1 (New England Biolabs, Beverly, MA, USA) for 2 h at 371C and then gel purified. The pcDNA Version A vector was digested with Not1 and Xba1 for 2 h and then placed at 651C for 15 min to stop the reaction. The vector was dephosphorylated using 2 ml of calf intestinal alkaline phosphatase (Boehringer Mannheim, Germany) and the buffer provided within the kit. The vector was heated to 651C for 15 min to stop the dephosphorylation reaction and the vector was gel purified. The ligation was performed with T4 DNA ligase (1 ml from a 400 000 U/ml stock and buffered with the solution recommended by the manufacturer; New England Biolabs, Beverly, MA, USA) for 20 min at room temperature using 50 ng of vector and 21 ng of each purified sticky PCR product (1 : 3 vector to insert molar ratio) as described by the manufacturer. Top10 Oneshot chemically competent Escherichia coli cells (Invitrogen, Carlsbad, CA, USA) were transformed with 5 ml of the ligation product as outlined in the protocol provided by the manufacturer. Positive colonies were screened by PCR using the following primers: 5 0 TAAT ACGACTC-ACTATAGGG-F (T7 from the vector) and 5 0 CTG-CAGTGGCTTTCCTGTC-R (near the midpoint inside the open reading frame). All of the clones were sequence verified using the T7 and BGH sites from the vector. The transient transfections were performed in HeLa cells (ATCC, Manassas, VA, USA) using the Fugene 6 Transfection Reagent (Roche Diagnostics, Indianapolis, IN, USA) as described by the manufacturer. All experiments were performed in triplicate and three individual clones containing the insert were used to ensure reproducibility of the results. Prior to each set of transfection experiments, the entire stock of trypsinized HeLa cells were pooled then an equal volume of the trypsinized cell suspension was delivered to each culture dish. Each transfection was performed identically in three dishes. At 48 h, one dish was collected for protein, one for RNA and the third dish was then trypsinized and the cells were passed to individual chambered slide compartments (Nalge Nunc International Corporation, Naperville, IL, USA). In each chamber, the cells were added such that the next morning the chambers would display varying degrees of confluence from around 50, 75, 100% and overgrown. The medium was removed and the cells were washed with 1xPBS. Neutral buffered formalin (NBF) (10%) was used to fix the cells for 30 min at room temperature. The cells were washed three times with 1 Â PBS and then the primary mouse Anti-myc (Invitrogen, Carlsbad, CA, USA) antibody was added (1 : 1000 suspended in 1 Â PBS with 3% goat serum) and allowed to incubate for 1 h at room temperature. The primary antibody was removed and the slides were washed three times with 1 Â PBS. The Alexa Fluor 488 conjugated goat anti-mouse antibody (Molecular Probes, Eugene, OR, USA) was used at 1 : 400 (suspended in 1 Â PBS with 3% goat serum) for 45 min at room temperature. The slides were then washed two times with 1 Â PBS and mounted with the DAPI Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA).
Zymogram analysis
The zymography was performed on 10% gelatin and 12% casein embedded Tris-glycine SDS gels. The zymogram gels have been performed essentially as described in the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA), and the lysate preparation was the same as previously described in the Western analysis section. Protein (40 mg) from the whole gland lysate was loaded in each lane. The gel was allowed to electrophorese, then Zymogram Renaturing Buffer (Invitrogen, Carlsbad, CA, USA) was added for 30 min at room temperature. After 30 min, the Zymogram Developing Buffer (Invitrogen, Carlsbad, CA, USA) was added, and the gels were allowed to incubate at room temperature for 30 min. The Zymogram Developing Buffer was discarded and replenished with fresh buffer, then allowed to incubate at 371C for 24 h. The gels were Coomassie stained, then dried. The protease activity was visualized by the appearance of clear bands that indicated the digestion of gelatin and casein substrates, respectively, embedded within the gels. Relative molecular sizes for the digested bands were determined using molecular weight markers and interpretation was performed using Alpha Imager software.
